{"transactions":[{"id":4614349,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T01:39:48.000Z","date":"2026-09-08","kind":"purchase","planned":false,"acquired":true,"shares":273290,"price":10.6271,"value":2904280.159,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in the case of Samsara Opportunity Fund, resulting in short-swing profit liability under Section 16(b). The Reporting Person has agreed to disgorge to the Issuer the short-swing profit realized in connection with these transactions, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.26 to $10.835, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":2298783,"source":{"system":"sec-edgar","filing":"0001231919-26-001158","document":"form4-09102026_010944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000123191926001158/form4-09102026_010944.xml","form_type":"4"}},{"id":4614348,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T01:39:48.000Z","date":"2026-09-08","kind":"purchase","planned":false,"acquired":true,"shares":273291,"price":10.6271,"value":2904290.7861,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in the case of Samsara Opportunity Fund, resulting in short-swing profit liability under Section 16(b). The Reporting Person has agreed to disgorge to the Issuer the short-swing profit realized in connection with these transactions, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.26 to $10.835, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara BioCapital LP. (\"Samsara LP\"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4937026,"source":{"system":"sec-edgar","filing":"0001231919-26-001158","document":"form4-09102026_010944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000123191926001158/form4-09102026_010944.xml","form_type":"4"}},{"id":4614347,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T01:39:48.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":48065,"price":10.5484,"value":507008.846,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in the case of Samsara Opportunity Fund, resulting in short-swing profit liability under Section 16(b). The Reporting Person has agreed to disgorge to the Issuer the short-swing profit realized in connection with these transactions, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $10.38 to $10.91, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":2025493,"source":{"system":"sec-edgar","filing":"0001231919-26-001158","document":"form4-09102026_010944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000123191926001158/form4-09102026_010944.xml","form_type":"4"}},{"id":4614346,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T01:39:48.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":48066,"price":10.5484,"value":507019.3944,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in the case of Samsara Opportunity Fund, resulting in short-swing profit liability under Section 16(b). The Reporting Person has agreed to disgorge to the Issuer the short-swing profit realized in connection with these transactions, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $10.38 to $10.91, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara BioCapital LP. (\"Samsara LP\"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4663735,"source":{"system":"sec-edgar","filing":"0001231919-26-001158","document":"form4-09102026_010944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000123191926001158/form4-09102026_010944.xml","form_type":"4"}},{"id":4614345,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T01:39:48.000Z","date":"2026-09-04","kind":"purchase","planned":false,"acquired":true,"shares":220070,"price":11.173,"value":2458842.11,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.02 to $11.60, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":2073558,"source":{"system":"sec-edgar","filing":"0001231919-26-001158","document":"form4-09102026_010944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000123191926001158/form4-09102026_010944.xml","form_type":"4"}},{"id":4614344,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T01:39:48.000Z","date":"2026-09-04","kind":"purchase","planned":false,"acquired":true,"shares":220070,"price":11.173,"value":2458842.11,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.02 to $11.60, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara BioCapital LP. (\"Samsara LP\"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4711801,"source":{"system":"sec-edgar","filing":"0001231919-26-001158","document":"form4-09102026_010944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000123191926001158/form4-09102026_010944.xml","form_type":"4"}},{"id":718227,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T22:22:08.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":15528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":15528,"derivative":{"exercise_price":28.14,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":15528},"source":{"system":"sec-edgar","filing":"0001253170-26-000011","document":"form4-07022026_100705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317026000011/form4-07022026_100705.xml","form_type":"4"}},{"id":718226,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T22:22:08.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":3553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant.  The shares underlying this RSU vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the \"Plan\")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":3553,"source":{"system":"sec-edgar","filing":"0001253170-26-000011","document":"form4-07022026_100705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317026000011/form4-07022026_100705.xml","form_type":"4"}},{"id":723819,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-06-29T20:09:54.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":35.08,"value":210480.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 26, 2027, and the date of the 2027 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting."}],"balance_after":16983,"derivative":{"exercise_price":35.08,"expiration_date":"2036-06-26","underlying":"Class A Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001253170-26-000008","document":"wk-form4_1782763791.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000125317026000008/wk-form4_1782763791.xml","form_type":"4"}},{"id":746221,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T20:48:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":4310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date."}],"balance_after":4310,"derivative":{"exercise_price":45.33,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":4310},"source":{"system":"sec-edgar","filing":"0001104659-26-071422","document":"tm2617049-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926071422/tm2617049-1_4seq1.xml","form_type":"4"}},{"id":746220,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:48:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":6839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 21,132 shares of common stock and 6,839 RSUs."}],"balance_after":27971,"source":{"system":"sec-edgar","filing":"0001104659-26-071422","document":"tm2617049-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465926071422/tm2617049-1_4seq1.xml","form_type":"4"}},{"id":749661,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:25:17.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 3, 2026. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 3, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":9000,"derivative":{"exercise_price":4.72,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001193125-26-257471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526257471/ownership.xml","form_type":"4"}},{"id":766025,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"other","planned":false,"acquired":true,"shares":4471,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents receipt of shares in the distribution in kind described in footnote (3)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Securities are held by Samsara BioCapital Partners. Dr. Akkaraju has voting and investment power over the shares held by Samsara BioCapital Partners and, accordingly, may be deemed to beneficially own the shares held by Samsara BioCapital Partners. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":19408,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":766024,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"other","planned":false,"acquired":true,"shares":14937,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital GP, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents receipt of shares in the distribution in kind described in footnote (3)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Securities are held by Samsara LLC. Dr. Akkaraju has voting and investment power over the shares held by Samsara LLC and, accordingly, may be deemed to beneficially own the shares held by Samsara LLC. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":14937,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":766023,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"other","planned":false,"acquired":false,"shares":66906,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata, in-kind distribution, without additional consideration, and not a purchase or sale of securities, by Samsara LP in respect of redeemed interests in Samsara LP.  Of the shares distributed by Samsara LP, (i) 47,498 were distributed to redeeming limited partners, (ii) 14,937 shares were distributed to Samsara BioCapital GP, LLC (\"Samsara LLC\"), the general partner of Samsara LP, in respect of redeemed interests of non-managing members of Samsara LLC that were retained by Samsara LLC, and (iii) 4,471 shares were distributed to Samsara BioCapital Partners, L.P. (\"Samsara BioCapital Partners\"), in respect of the redeemed interest of a limited partner of Samsara LP that has been acquired by Samsara BioCapital Partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares held by Samsara LP reflects the disposition of 244,300\nshares, to Samsara Opportunity Fund as described in footnote (1), in which each of Samsara LLC and Dr. Akkaraju had no pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are held by Samsara LP. Samsara LLC is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":10657028,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":766022,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T23:47:34.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":244300,"price":4.83,"value":1179969.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the purchase of shares from Samsara BioCapital, L.P. (\"Samsara LP\") in a privately negotiated transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Each of the Reporting Persons disclaims beneficial ownership in these securities except to the extent of its or his pecuniary interest therein."}],"balance_after":2224147,"source":{"system":"sec-edgar","filing":"0001231919-26-000532","document":"form4-05222026_110527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000532/form4-05222026_110527.xml","form_type":"4"}},{"id":890391,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2026-02-21T00:47:10.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":8300,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001933414-26-000040","document":"wk-form4_1771634828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000193341426000040/wk-form4_1771634828.xml","form_type":"4"}},{"id":890390,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-21T00:47:10.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001933414-26-000040","document":"wk-form4_1771634828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000193341426000040/wk-form4_1771634828.xml","form_type":"4"}},{"id":901136,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":3,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":4,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":5,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T01:15:32.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":479847,"price":10.42,"value":5000005.74,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the purchase of shares from Samsara BioCapital, L.P. (\"Samsara LP\") in a privately negotiated transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the number of shares held as of the date of this filing, including the shares purchased by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") on December 22, 2025, as reported in the reporting persons' Form 4 filed with the SEC on December 22, 2025 (the \"Prior Report\").  The Prior Report is deemed amended hereby."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are directly held by Samsara Opportunity Fund. Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1979847,"source":{"system":"sec-edgar","filing":"0001231919-26-000166","document":"form4-02182026_010226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191926000166/form4-02182026_010226.xml","form_type":"4"}},{"id":940122,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T23:20:06.000Z","date":"2026-01-09","kind":"purchase","planned":false,"acquired":true,"shares":588235,"price":17,"value":9999995.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1853488,"source":{"system":"sec-edgar","filing":"0001253170-26-000004","document":"form4-01132026_110101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317026000004/form4-01132026_110101.xml","form_type":"4"}},{"id":961036,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44748,"kind":"organization","name":"Samsara Opportunity Fund, L.P.","position":2,"cik":"0002086193","reported_name":"Samsara Opportunity Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44749,"kind":"organization","name":"Samsara Opportunity Fund GP, LLC","position":3,"cik":"0002086456","reported_name":"Samsara Opportunity Fund GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:15:40.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":10,"value":15000000.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Samsara Opportunity GP and Dr. Akkaraju have voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. Each of the Reporting Persons disclaims beneficial ownership in these securities except to the extent of his or its respective pecuniary interest therein."}],"balance_after":1500000,"source":{"system":"sec-edgar","filing":"0001231919-25-000652","document":"form4-12222025_091234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000123191925000652/form4-12222025_091234.xml","form_type":"4"}},{"id":967636,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2025-12-17T02:07:57.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":1064804,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are directly held by Samsara BioCapital LP (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":7.35,"exercise_date":"2022-06-22","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":1064804},"source":{"system":"sec-edgar","filing":"0001253170-25-000025","document":"form4-12172025_021252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000025/form4-12172025_021252.xml","form_type":"4"}},{"id":967635,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T02:07:57.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":true,"shares":1064804,"price":7.35,"value":7826309.4,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Securities are directly held by Samsara BioCapital LP (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":6367614,"source":{"system":"sec-edgar","filing":"0001253170-25-000025","document":"form4-12172025_021252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000025/form4-12172025_021252.xml","form_type":"4"}},{"id":967634,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T02:07:57.000Z","date":"2025-10-07","kind":"purchase","planned":false,"acquired":true,"shares":4403,"price":40.97,"value":180390.91,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $40.87 to $41.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":530038,"source":{"system":"sec-edgar","filing":"0001253170-25-000025","document":"form4-12172025_021252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000025/form4-12172025_021252.xml","form_type":"4"}},{"id":967633,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T02:07:57.000Z","date":"2025-10-07","kind":"purchase","planned":false,"acquired":true,"shares":12400,"price":40.18,"value":498232.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $39.8512 to $40.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":525635,"source":{"system":"sec-edgar","filing":"0001253170-25-000025","document":"form4-12172025_021252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000025/form4-12172025_021252.xml","form_type":"4"}},{"id":967632,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T02:07:57.000Z","date":"2025-10-07","kind":"purchase","planned":false,"acquired":true,"shares":12796,"price":39.31,"value":503010.76,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $38.85 to $39.849 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":513235,"source":{"system":"sec-edgar","filing":"0001253170-25-000025","document":"form4-12172025_021252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000025/form4-12172025_021252.xml","form_type":"4"}},{"id":976301,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T00:13:55.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":51380,"price":10.73,"value":551307.4,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.48 to $11.005 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1265253,"source":{"system":"sec-edgar","filing":"0001253170-25-000021","document":"form4-12102025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000021/form4-12102025_121251.xml","form_type":"4"}},{"id":976300,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T00:13:55.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":70028,"price":10.01,"value":700980.28,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.48 to $10.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1213873,"source":{"system":"sec-edgar","filing":"0001253170-25-000021","document":"form4-12102025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000021/form4-12102025_121251.xml","form_type":"4"}},{"id":976299,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T00:13:55.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":64969,"price":8.95,"value":581472.55,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.48 to $9.4793 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1143845,"source":{"system":"sec-edgar","filing":"0001253170-25-000021","document":"form4-12102025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000021/form4-12102025_121251.xml","form_type":"4"}},{"id":980401,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-05T01:11:35.000Z","date":"2025-12-04","kind":"purchase","planned":false,"acquired":true,"shares":66027,"price":8.18,"value":540100.86,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.65 to $8.41 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1078876,"source":{"system":"sec-edgar","filing":"0001253170-25-000019","document":"form4-12052025_011232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000019/form4-12052025_011232.xml","form_type":"4"}},{"id":980400,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-05T01:11:35.000Z","date":"2025-12-03","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":7.75,"value":775000.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.41 to $7.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1012849,"source":{"system":"sec-edgar","filing":"0001253170-25-000019","document":"form4-12052025_011232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000019/form4-12052025_011232.xml","form_type":"4"}},{"id":980399,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-05T01:11:35.000Z","date":"2025-12-02","kind":"purchase","planned":false,"acquired":true,"shares":96000,"price":7.55,"value":724800.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.41 to $7.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":912849,"source":{"system":"sec-edgar","filing":"0001253170-25-000019","document":"form4-12052025_011232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000019/form4-12052025_011232.xml","form_type":"4"}},{"id":985181,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T23:09:31.000Z","date":"2025-12-01","kind":"purchase","planned":false,"acquired":true,"shares":86350,"price":7.46,"value":644171.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.31 to $7.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":816849,"source":{"system":"sec-edgar","filing":"0001253170-25-000017","document":"form4-12012025_111227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000017/form4-12012025_111227.xml","form_type":"4"}},{"id":985180,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T23:09:31.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":38702,"price":7.64,"value":295683.28,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.56 to $7.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":730499,"source":{"system":"sec-edgar","filing":"0001253170-25-000017","document":"form4-12012025_111227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000017/form4-12012025_111227.xml","form_type":"4"}},{"id":985179,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T23:09:31.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":48537,"price":7.64,"value":370822.68,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.46 to $7.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":691797,"source":{"system":"sec-edgar","filing":"0001253170-25-000017","document":"form4-12012025_111227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000017/form4-12012025_111227.xml","form_type":"4"}},{"id":990239,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T23:50:22.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":125743,"price":7.2,"value":905349.6,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.92 to $7.48 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":643260,"source":{"system":"sec-edgar","filing":"0001253170-25-000014","document":"form4-11242025_111119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000014/form4-11242025_111119.xml","form_type":"4"}},{"id":993964,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:46:30.000Z","date":"2025-11-19","kind":"purchase","planned":false,"acquired":true,"shares":137772,"price":6.56,"value":903784.32,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.23 to $6.81 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":517517,"source":{"system":"sec-edgar","filing":"0001253170-25-000011","document":"form4-11202025_011127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000011/form4-11202025_011127.xml","form_type":"4"}},{"id":993963,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:46:30.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":102652,"price":6.05,"value":621044.6,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.72 to $6.44 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":379745,"source":{"system":"sec-edgar","filing":"0001253170-25-000011","document":"form4-11202025_011127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000011/form4-11202025_011127.xml","form_type":"4"}},{"id":993962,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T01:46:30.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":914,"price":5.51,"value":5036.14,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.51 to $5.52 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":277093,"source":{"system":"sec-edgar","filing":"0001253170-25-000011","document":"form4-11202025_011127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000011/form4-11202025_011127.xml","form_type":"4"}},{"id":997894,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T21:59:00.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":276179,"price":5.25,"value":1449939.75,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the purchase of shares from Samsara BioCapital, L.P. (\"Samsara LP\") in a privately negotiated transaction."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":276179,"source":{"system":"sec-edgar","filing":"0001253170-25-000008","document":"form4-11172025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000125317025000008/form4-11172025_091156.xml","form_type":"4"}},{"id":1022237,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T00:59:19.000Z","date":"2025-10-06","kind":"purchase","planned":false,"acquired":true,"shares":13748,"price":39.52,"value":543320.96,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $39.23 to $39.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":500439,"source":{"system":"sec-edgar","filing":"0001253170-25-000006","document":"form4-10082025_121015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000006/form4-10082025_121015.xml","form_type":"4"}},{"id":1022236,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T00:59:19.000Z","date":"2025-10-06","kind":"purchase","planned":false,"acquired":true,"shares":80863,"price":38.68,"value":3127780.84,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $38.23 to $39.2298 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":486691,"source":{"system":"sec-edgar","filing":"0001253170-25-000006","document":"form4-10082025_121015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000006/form4-10082025_121015.xml","form_type":"4"}},{"id":1022235,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T00:59:19.000Z","date":"2025-10-06","kind":"purchase","planned":false,"acquired":true,"shares":18414,"price":37.89,"value":697706.46,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $37.23 to $38.2276 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."}],"balance_after":405828,"source":{"system":"sec-edgar","filing":"0001253170-25-000006","document":"form4-10082025_121015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000006/form4-10082025_121015.xml","form_type":"4"}},{"id":1022234,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T00:59:19.000Z","date":"2025-10-03","kind":"purchase","planned":false,"acquired":true,"shares":319700,"price":37.42,"value":11963174.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $37.14 to $37.6227 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":387414,"source":{"system":"sec-edgar","filing":"0001253170-25-000006","document":"form4-10082025_121015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000006/form4-10082025_121015.xml","form_type":"4"}},{"id":1022233,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T00:59:19.000Z","date":"2025-10-03","kind":"purchase","planned":false,"acquired":true,"shares":56703,"price":36.74,"value":2083268.22,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $36.14 to $37.1391 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":67714,"source":{"system":"sec-edgar","filing":"0001253170-25-000006","document":"form4-10082025_121015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000006/form4-10082025_121015.xml","form_type":"4"}},{"id":1022232,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-08T00:59:19.000Z","date":"2025-10-03","kind":"purchase","planned":false,"acquired":true,"shares":11011,"price":35.61,"value":392101.71,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $35.14 to $36.13 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":11011,"source":{"system":"sec-edgar","filing":"0001253170-25-000006","document":"form4-10082025_121015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000125317025000006/form4-10082025_121015.xml","form_type":"4"}},{"id":1032167,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2025-09-25T21:04:22.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":983214,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 29, 2025, Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara Opportunity Fund purchased 106,000 shares of the Issuer's Class A Common Stock; pre-funded warrants exercisable for up to 877,214 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 983,214 shares of the Issuer's Class A Common Stock. The transaction closed on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 29, 2025, Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara Opportunity Fund purchased 106,000 shares of the Issuer's Class A Common Stock; pre-funded warrants exercisable for up to 877,214 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 983,214 shares of the Issuer's Class A Common Stock. The transaction closed on September 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Warrants are immediately exercisable and expire on the earlier of (i) September 3, 2030 and (ii) the date that is 90 days after the date the Exercise Conditions (as defined in the Common Warrants) have been met.  A holder of Common Warrants may not exercise the Common Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Warrants are immediately exercisable and expire on the earlier of (i) September 3, 2030 and (ii) the date that is 90 days after the date the Exercise Conditions (as defined in the Common Warrants) have been met.  A holder of Common Warrants may not exercise the Common Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund. Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":983214,"derivative":{"exercise_price":22.71,"underlying":"Class A Common Stock","underlying_shares":983214},"source":{"system":"sec-edgar","filing":"0001231919-25-000247","document":"form4-09252025_090918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000123191925000247/form4-09252025_090918.xml","form_type":"4"}},{"id":1032166,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants (Right to Buy)","published_at":"2025-09-25T21:04:22.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":877214,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 29, 2025, Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara Opportunity Fund purchased 106,000 shares of the Issuer's Class A Common Stock; pre-funded warrants exercisable for up to 877,214 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 983,214 shares of the Issuer's Class A Common Stock. The transaction closed on September 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 29, 2025, Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara Opportunity Fund purchased 106,000 shares of the Issuer's Class A Common Stock; pre-funded warrants exercisable for up to 877,214 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 983,214 shares of the Issuer's Class A Common Stock. The transaction closed on September 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund. Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":877214,"derivative":{"exercise_price":0.01,"underlying":"Class A Common Stock","underlying_shares":877214},"source":{"system":"sec-edgar","filing":"0001231919-25-000247","document":"form4-09252025_090918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000123191925000247/form4-09252025_090918.xml","form_type":"4"}},{"id":1032165,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-25T21:04:22.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":106000,"price":15.265,"value":1618090.0,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 29, 2025, Samsara Opportunity Fund, L.P. (\"Samsara Opportunity Fund\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara Opportunity Fund purchased 106,000 shares of the Issuer's Class A Common Stock; pre-funded warrants exercisable for up to 877,214 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 983,214 shares of the Issuer's Class A Common Stock. The transaction closed on September 22, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are directly held by Samsara Opportunity Fund. Samsara Opportunity Fund GP, LLC (\"Samsara Opportunity GP\") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":106000,"source":{"system":"sec-edgar","filing":"0001231919-25-000247","document":"form4-09252025_090918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000123191925000247/form4-09252025_090918.xml","form_type":"4"}},{"id":1045694,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-09T00:07:14.000Z","date":"2025-09-04","kind":"purchase","planned":false,"acquired":true,"shares":588235,"price":25.5,"value":14999992.5,"ownership":{"direct":false,"nature":"By Samsara Opportunity Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities are directly held by Samsara Opportunity Fund, L.P. (\"Samsara Opp LP\"). Samsara Opportunity Fund GP, LLC (\"Samsara Opp GP\") is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. The Reporting Person has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":588235,"source":{"system":"sec-edgar","filing":"0001415889-25-023919","document":"form4-09092025_120910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588925023919/form4-09092025_120910.xml","form_type":"4"}},{"id":1046735,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Class A Common Stock (Right to Buy)","published_at":"2025-09-05T22:10:28.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":655523,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 29, 2025, Samsara BioCapital, L.P. (\"Samsara LP\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara LP purchased pre-funded warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 29, 2025, Samsara BioCapital, L.P. (\"Samsara LP\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara LP purchased pre-funded warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Common Warrants are immediately exercisable and expire on the earlier of (i) September 3, 2030 and (ii) the date that is 90 days after the date the Exercise Conditions (as defined in the Common Warrants) have been met.  A holder of Common Warrants may not exercise the Common Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Common Warrants are immediately exercisable and expire on the earlier of (i) September 3, 2030 and (ii) the date that is 90 days after the date the Exercise Conditions (as defined in the Common Warrants) have been met.  A holder of Common Warrants may not exercise the Common Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held by Samsara LP. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":655523,"derivative":{"exercise_price":22.71,"underlying":"Class A Common Stock","underlying_shares":655523},"source":{"system":"sec-edgar","filing":"0001415889-25-023816","document":"form4-09052025_100925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588925023816/form4-09052025_100925.xml","form_type":"4"}},{"id":1046734,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants (Right to Buy)","published_at":"2025-09-05T22:10:28.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":655523,"ownership":{"direct":false,"nature":"Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 29, 2025, Samsara BioCapital, L.P. (\"Samsara LP\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara LP purchased pre-funded warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 29, 2025, Samsara BioCapital, L.P. (\"Samsara LP\") entered into a securities purchase agreement with the Issuer pursuant to which Samsara LP purchased pre-funded warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock and common warrants exercisable for up to 655,523 shares of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrants if the holder, together with its Attribution Parties (as defined in the Common Warrants), would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held by Samsara LP. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":1548101,"derivative":{"exercise_price":0.01,"underlying":"Class A Common Stock","underlying_shares":655523},"source":{"system":"sec-edgar","filing":"0001415889-25-023816","document":"form4-09052025_100925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588925023816/form4-09052025_100925.xml","form_type":"4"}},{"id":1077665,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-01T20:05:05.000Z","date":"2025-07-30","kind":"grant","planned":false,"acquired":true,"shares":49800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the \"Plan\")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":49800,"derivative":{"exercise_price":4.1,"expiration_date":"2035-07-29","underlying":"Common Stock","underlying_shares":49800},"source":{"system":"sec-edgar","filing":"0001415889-25-020833","document":"form4-08012025_040801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925020833/form4-08012025_040801.xml","form_type":"4"}},{"id":1113043,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-12T20:27:28.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":16.59,"value":66360.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 10, 2026, and the date of the 2026 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting."}],"balance_after":10983,"derivative":{"exercise_price":16.59,"expiration_date":"2035-06-10","underlying":"Class A Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001641489-25-000044","document":"wk-form4_1749760036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000164148925000044/wk-form4_1749760036.xml","form_type":"4"}},{"id":1135526,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-24T00:47:53.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":1214582,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 21, 2025, pursuant to the Agreement and Plan of Merger, dated as of February 6, 2025 and amended on April 21, 2025, by and among the Issuer, ACELYRIN, Inc. (\"ACELYRIN\"), and Arrow Merger Sub, Inc., a direct wholly owned subsidiary of the Issuer (\"Merger Sub\"), Merger Sub merged with and into ACELYRIN with ACELYRIN continuing as the surviving corporation and as a wholly owned subsidiary of the Issuer (the \"Merger\").  Each share of ACELYRIN common stock was exchanged for 0.4814 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for 2,523,022 shares of common stock of ACELYRIN in connection with the Merger (as described in footnote 1) on May 21, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":4801370,"source":{"system":"sec-edgar","filing":"0001415889-25-014559","document":"form4-05242025_120550.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925014559/form4-05242025_120550.xml","form_type":"4"}},{"id":1135416,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:44:05.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":9206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."}],"balance_after":9206,"derivative":{"exercise_price":30.46,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":9206},"source":{"system":"sec-edgar","filing":"0001104659-25-052478","document":"tm2516084-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925052478/tm2516084-4_4seq1.xml","form_type":"4"}},{"id":1135415,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T20:44:05.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":7632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2026 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 13,500 shares of Common Stock and 7,632 RSUs."}],"balance_after":21132,"source":{"system":"sec-edgar","filing":"0001104659-25-052478","document":"tm2516084-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000110465925052478/tm2516084-4_4seq1.xml","form_type":"4"}},{"id":1157449,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-06T22:52:45.000Z","date":"2025-05-05","kind":"purchase","planned":false,"acquired":true,"shares":22002,"price":5.27,"value":115950.54,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $5.19 to $5.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":3586788,"source":{"system":"sec-edgar","filing":"0001415889-25-012166","document":"form4-05062025_100542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925012166/form4-05062025_100542.xml","form_type":"4"}},{"id":1157448,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-06T22:52:45.000Z","date":"2025-05-05","kind":"purchase","planned":false,"acquired":true,"shares":138368,"price":4.58,"value":633725.44,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $4.19 to $5.1899 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":3564786,"source":{"system":"sec-edgar","filing":"0001415889-25-012166","document":"form4-05062025_100542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925012166/form4-05062025_100542.xml","form_type":"4"}},{"id":1157447,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-06T22:52:45.000Z","date":"2025-05-02","kind":"purchase","planned":false,"acquired":true,"shares":159920,"price":4.55,"value":727636.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.97 to $4.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":3426418,"source":{"system":"sec-edgar","filing":"0001415889-25-012166","document":"form4-05062025_100542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925012166/form4-05062025_100542.xml","form_type":"4"}},{"id":1166270,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-04-24T20:40:29.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":983,"price":17.22,"value":16927.26,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the one-year anniversary of the date of grant"}],"balance_after":6983,"derivative":{"exercise_price":17.22,"exercise_date":"2025-06-25","expiration_date":"2034-06-25","underlying":"Class A Common Stock","underlying_shares":983},"source":{"system":"sec-edgar","filing":"0001641489-25-000022","document":"wk-form4_1745527221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000164148925000022/wk-form4_1745527221.xml","form_type":"4"}},{"id":1166269,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-04-24T20:40:29.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":2250,"price":17.22,"value":38745.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest monthly over the three year period following the date of grant."}],"balance_after":6000,"derivative":{"exercise_price":17.22,"expiration_date":"2034-06-25","underlying":"Class A Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001641489-25-000022","document":"wk-form4_1745527221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000164148925000022/wk-form4_1745527221.xml","form_type":"4"}},{"id":1173319,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-11T21:20:13.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over three years in equal monthly installments from March 18, 2025 through March 18, 2028, subject to continuous service."}],"balance_after":18000,"derivative":{"exercise_price":7.31,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000950170-25-053379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025053379/ownership.xml","form_type":"4"}},{"id":1200000,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T21:40:57.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":11444503,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2024 (the \"Merger Agreement\"), by and among the Issuer, Aurora Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Kalaris Tx, Inc. (previously named Kalaris Therapeutics, Inc.), a Delaware corporation (\"KTx\"), in exchange for outstanding shares of KTx pursuant to the terms and conditions of the Merger Agreement (such transaction, the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, as of the effective time of the Merger, each share of KTx common stock was converted into and became exchangeable for the right to receive 0.2016 shares of common stock of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein."}],"balance_after":11444503,"source":{"system":"sec-edgar","filing":"0000950170-25-041484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025041484/ownership.xml","form_type":"4"}},{"id":1203491,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T01:04:15.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":600000,"price":13.5,"value":8100000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities are directly held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":5674916,"source":{"system":"sec-edgar","filing":"0001415889-25-008274","document":"form4-03182025_010312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588925008274/form4-03182025_010312.xml","form_type":"4"}},{"id":1249214,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-02-24T23:59:33.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":32900,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001933414-25-000018","document":"wk-form4_1740441567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000193341425000018/wk-form4_1740441567.xml","form_type":"4"}},{"id":1340239,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre- Funded Warrants (Right to Buy)","published_at":"2024-12-06T21:15:16.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":58885,"ownership":{"direct":false,"nature":"Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Samsara LP. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":892578,"derivative":{"exercise_price":0.01,"underlying":"Class A Common Stock","underlying_shares":58885},"source":{"system":"sec-edgar","filing":"0001415889-24-028464","document":"form4-12062024_041202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924028464/form4-12062024_041202.xml","form_type":"4"}},{"id":1340238,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-12-06T21:15:16.000Z","date":"2024-03-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":58836,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, Samsara BioCapital, L.P. (\"Samsara LP\") entered into an Exchange Agreement with the Issuer pursuant to which Samsara LP exchanged, for no additional consideration, 58,836 shares of the Issuer's Class A Common Stock for pre-funded warrants\nexercisable for up to 58,885 shares of the Issuer's Class A Common Stock at an exercise price of $0.01 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Samsara LP. Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":206784,"source":{"system":"sec-edgar","filing":"0001415889-24-028464","document":"form4-12062024_041202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924028464/form4-12062024_041202.xml","form_type":"4"}},{"id":1349176,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":27.5,"value":55000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $27.48 to $27.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1717127,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1349175,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":15219,"price":26.73,"value":406803.87,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.46 to $26.90 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1715127,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1349174,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":10803,"price":26.01,"value":280986.03,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $25.47 to $26.44 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1699908,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1349173,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T21:39:29.000Z","date":"2024-11-26","kind":"purchase","planned":false,"acquired":true,"shares":20748,"price":24.91,"value":516832.68,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $24.25 to $25.23 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":1689105,"source":{"system":"sec-edgar","filing":"0001415889-24-027861","document":"form4-11272024_091125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000141588924027861/form4-11272024_091125.xml","form_type":"4"}},{"id":1390166,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-08T00:55:35.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":155713,"price":32.5,"value":5060672.5,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital LP (\"Samsara LP\"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":5612896,"source":{"system":"sec-edgar","filing":"0001415889-24-024852","document":"form4-10082024_121030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924024852/form4-10082024_121030.xml","form_type":"4"}},{"id":1390165,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-08T00:55:35.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":510000,"price":30,"value":15300000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital LP (\"Samsara LP\"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":5768609,"source":{"system":"sec-edgar","filing":"0001415889-24-024852","document":"form4-10082024_121030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924024852/form4-10082024_121030.xml","form_type":"4"}},{"id":1390164,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-08T00:55:35.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":510000,"price":27.5,"value":14025000.0,"ownership":{"direct":false,"nature":"Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Samsara BioCapital LP (\"Samsara LP\"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":6278609,"source":{"system":"sec-edgar","filing":"0001415889-24-024852","document":"form4-10082024_121030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924024852/form4-10082024_121030.xml","form_type":"4"}},{"id":1403333,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-09-18T21:00:06.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":2667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a restricted stock unit award granted on September 16, 2022. These restricted stock units vest in three equal annual installments commencing on September 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents a restricted stock unit award granted on September 16, 2022. These restricted stock units vest in three equal annual installments commencing on September 16, 2023."}],"balance_after":2667,"derivative":{"underlying":"Common Stock","underlying_shares":2667},"source":{"system":"sec-edgar","filing":"0000950170-24-107863","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000095017024107863/ownership.xml","form_type":"4"}},{"id":1403332,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T21:00:06.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":2667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":9333,"source":{"system":"sec-edgar","filing":"0000950170-24-107863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000095017024107863/ownership.xml","form_type":"4"}},{"id":1422036,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T20:10:05.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":1562500,"price":16,"value":25000000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 inadvertently omitted the purchase of shares by Samsara in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":3266498,"source":{"system":"sec-edgar","filing":"0001415889-24-022292","document":"form4a-08272024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924022292/form4a-08272024_040801.xml","form_type":"4/A","original_submission_date":"2024-07-01"}},{"id":1465840,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T21:13:59.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."}],"balance_after":18000,"derivative":{"exercise_price":8.36,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001415889-24-018629","document":"form4-07012024_090756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924018629/form4-07012024_090756.xml","form_type":"4"}},{"id":1465839,"issuer":{"id":3721,"kind":"organization","name":"Scholar Rock Holding Corp","symbol":"SRRK"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:13:59.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest  on the earlier of June 15, 2025 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 13,500 RSUs."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001415889-24-018629","document":"form4-07012024_090756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727196/000141588924018629/form4-07012024_090756.xml","form_type":"4"}},{"id":1465978,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-07-01T20:40:59.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1703998,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1703998},"source":{"system":"sec-edgar","filing":"0001415889-24-018603","document":"form4-07012024_080756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018603/form4-07012024_080756.xml","form_type":"4"}},{"id":1465977,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T20:40:59.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1703998,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":1703998,"source":{"system":"sec-edgar","filing":"0001415889-24-018603","document":"form4-07012024_080756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018603/form4-07012024_080756.xml","form_type":"4"}},{"id":1465976,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-01T20:40:59.000Z","date":"2024-07-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1703998,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-018603","document":"form4-07012024_080756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018603/form4-07012024_080756.xml","form_type":"4"}},{"id":1465975,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-01T20:40:59.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1703998,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock (the \"Preferred Stock\") automatically converted on a 4.675-to-one basis into shares of Class A Common Stock. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held directly by Samsara BioCapital, L.P. (\"Samsara LP\").  Samsara BioCapital GP, LLC (\"Samsara GP\") is the general partner of Samsara LP. The Reporting Person, as the managing member of Samsara GP, shares voting and investment authority over the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his  pecuniary interest therein."}],"balance_after":1703998,"source":{"system":"sec-edgar","filing":"0001415889-24-018603","document":"form4-07012024_080756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588924018603/form4-07012024_080756.xml","form_type":"4"}},{"id":1480341,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T22:22:53.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal monthly installments over a three-year period commencing on the one-month anniversary of February 27, 2024, subject to the Reporting Person's continuous service as of each applicable vesting date."}],"balance_after":3750,"derivative":{"exercise_price":8.5,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001415889-24-016730","document":"form4-06132024_100649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924016730/form4-06132024_100649.xml","form_type":"4"}},{"id":1486378,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-07T20:30:09.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs will vest in their entirety on the earlier to occur of (i) the first anniversary of the date of grant of the award, or (ii) the date of the Company's next Annual Meeting of Stockholders, subject in each case to the director's continued service as a director through the applicable vesting date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-24-070701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000095017024070701/ownership.xml","form_type":"4"}},{"id":1486377,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:30:09.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date."}],"balance_after":6000,"derivative":{"exercise_price":5.3,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000950170-24-070701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000095017024070701/ownership.xml","form_type":"4"}},{"id":1491736,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-04T20:41:19.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vested in their entirety on the first anniversary of the date of grant of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vested in their entirety on the first anniversary of the date of grant of the award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-24-068755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000095017024068755/ownership.xml","form_type":"4"}},{"id":1491735,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:41:19.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":6666,"source":{"system":"sec-edgar","filing":"0000950170-24-068755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000095017024068755/ownership.xml","form_type":"4"}},{"id":1494902,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T01:45:28.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":294000,"price":17,"value":4998000.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":4415689,"source":{"system":"sec-edgar","filing":"0001415889-24-015250","document":"form4-06042024_010623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924015250/form4-06042024_010623.xml","form_type":"4"}},{"id":1503409,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2024-05-23T20:21:46.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting."}],"balance_after":22000,"derivative":{"exercise_price":12.52,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001933414-24-000021","document":"wk-form4_1716495693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000193341424000021/wk-form4_1716495693.xml","form_type":"4"}},{"id":1609708,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre- Funded Warrants (Right to Buy)","published_at":"2024-03-01T00:33:01.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":833693,"price":11.8,"value":9837577.4,"ownership":{"direct":false,"nature":"Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":833693,"derivative":{"exercise_price":0.01,"underlying":"Class A Common Stock","underlying_shares":833693},"source":{"system":"sec-edgar","filing":"0001415889-24-005996","document":"form4-03012024_120353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924005996/form4-03012024_120353.xml","form_type":"4"}},{"id":1609707,"issuer":{"id":6614,"kind":"organization","name":"vTv Therapeutics Inc."},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-01T00:33:01.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":224732,"price":11.81,"value":2654084.92,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held by Samsara BioCapital, L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein."}],"balance_after":265620,"source":{"system":"sec-edgar","filing":"0001415889-24-005996","document":"form4-03012024_120353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924005996/form4-03012024_120353.xml","form_type":"4"}},{"id":1642778,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T02:07:15.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":555555,"price":13.5,"value":7499992.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held directly by Samsara BioCapital, L.P. (\"Samsara LP\"). Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein."}],"balance_after":5074916,"source":{"system":"sec-edgar","filing":"0001415889-24-003861","document":"form4-02152024_020204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000141588924003861/form4-02152024_020204.xml","form_type":"4"}},{"id":1700005,"issuer":{"id":85437,"kind":"organization","name":"Syros Pharmaceuticals, Inc.","symbol":"SYRS"},"owners":[{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":1,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-26T22:24:30.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":904977,"price":4.42,"value":3999998.34,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein."}],"balance_after":1786427,"source":{"system":"sec-edgar","filing":"0001209191-23-059693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123059693/doc4.xml","form_type":"4"}},{"id":1738813,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 convertible preferred stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":1833623,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1833623},"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738812,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 convertible preferred stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":884400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":884400},"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738811,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed convertible preferred stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":663300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":663300},"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738810,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":666666,"price":15,"value":9999990.0,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":4121689,"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}},{"id":1738809,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":44747,"kind":"organization","name":"Samsara BioCapital GP, LLC","position":1,"cik":"0001888829","reported_name":"Samsara BioCapital GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44746,"kind":"organization","name":"Samsara BioCapital, L.P.","position":2,"cik":"0001699737","reported_name":"Samsara BioCapital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32933,"kind":"person","name":"AKKARAJU SRINIVAS","position":3,"cik":"0001253170","reported_name":"AKKARAJU SRINIVAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-17T00:39:55.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":true,"shares":3381323,"ownership":{"direct":false,"nature":"By Samsara BioCapital, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed convertible preferred stock, Series A-1 convertible preferred stock and Series A-2 convertible preferred stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by Samsara BioCapital L.P. (\"Samsara LP\"). Samsara BioCapital GP, LLC (\"Samsara LLC\") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein."}],"balance_after":3455023,"source":{"system":"sec-edgar","filing":"0001209191-23-055621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253170/000120919123055621/doc4.xml","form_type":"4"}}],"next_cursor":"2023-11-17T00:39:55.000000Z,1738809"}